Success Metrics

Clinical Success Rate
80.0%

Based on 16 completed trials

Completion Rate
80%(16/20)
Active Trials
13(27%)
Results Posted
31%(5 trials)
Terminated
4(8%)

Phase Distribution

Ph early_phase_1
1
2%
Ph phase_4
1
2%
Ph phase_2
17
35%
Ph phase_1
7
14%
Ph phase_3
9
18%
Ph not_applicable
11
22%

Phase Distribution

8

Early Stage

17

Mid Stage

10

Late Stage

Phase Distribution46 total trials
Early Phase 1First-in-human
1(2.2%)
Phase 1Safety & dosage
7(15.2%)
Phase 2Efficacy & side effects
17(37.0%)
Phase 3Large-scale testing
9(19.6%)
Phase 4Post-market surveillance
1(2.2%)
N/ANon-phased studies
11(23.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

69.6%

16 of 23 finished

Non-Completion Rate

30.4%

7 ended early

Currently Active

13

trials recruiting

Total Trials

49

all time

Status Distribution
Active(13)
Completed(16)
Terminated(7)
Other(13)

Detailed Status

Completed16
unknown12
Active, not recruiting8
Recruiting5
Terminated4
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
49
Active
13
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.2%)
Phase 17 (15.2%)
Phase 217 (37.0%)
Phase 39 (19.6%)
Phase 41 (2.2%)
N/A11 (23.9%)

Trials by Status

completed1633%
recruiting510%
suspended12%
withdrawn36%
active_not_recruiting816%
terminated48%
unknown1224%

Recent Activity

Clinical Trials (49)

Showing 20 of 49 trialsScroll for more
NCT04136353Phase 3

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

Active Not Recruiting
NCT06087861Phase 2

5-Day Preoperative Radiation for Soft Tissue Sarcoma

Recruiting
NCT04748042Phase 2

Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)

Active Not Recruiting
NCT04307914Not Applicable

Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases

Active Not Recruiting
NCT02245997Early Phase 1

Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma

Completed
NCT06538337Not Applicable

Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers

Recruiting
NCT05179447Not Applicable

PROfiling Based Endometrial Cancer Adjuvant Therapy

Recruiting
NCT01492751

Effectiveness of Localized Prostate Cancer Treatments

Active Not Recruiting
NCT06000787Not Applicable

MCT for the Harvard/UCSF ROBIN Center

Recruiting
NCT05250687Not Applicable

MR Guided Focused Ultrasound vs Radiotherapy for Palliative Pain Tx in Bone Metastases

Withdrawn
NCT04554771Phase 2

Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Therapy

Active Not Recruiting
NCT04481256Not Applicable

TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY

Recruiting
NCT04301557Phase 2

PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

Active Not Recruiting
NCT01502917Phase 1

Convection-Enhanced Delivery of 124I-Omburtamab for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy

Completed
NCT03840239Phase 2

TNT to Increase the Clinical Complete Response Rate for Distal LARC

Active Not Recruiting
NCT03469674Phase 3

PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer

Active Not Recruiting
NCT01913717Not Applicable

Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion

Unknown
NCT03482089Not Applicable

Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder Invasion

Unknown
NCT03612466Phase 1

A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

Withdrawn
NCT05382182

Outcome Of Treatment Of Prostate Cancer at Sohag University Hospital Between 2017 to 2021

Unknown

Drug Details

Intervention Type
RADIATION
Total Trials
49